WK Test

Companies

  • Age of Minds

    Age of Minds

    Visit

    Age of Minds uses entertainment platforms and rich closed-loop interactions to provide a robust training platform for humans and AI agents to collaborate, learn, and grow together.

  • Aira

    Aira

    Visit

    Aira’s mission is to provide equal access to information for all, with initial focus on the 285 million blind and vision-impaired people worldwide. They are developing transformative remote assistive technology and services that enable greater mobility and independence to those with vision loss.

  • Akili

    Akili

    Visit

    Akili Interactive develops scientifically validated, immersive, and entertaining videogames designed to improve mental capabilities across several dimensions – from those suffering from health conditions such as ADHD and memory decline to enabling normal individuals to achieve peak cognitive performance.

  • Augment

    Augment

    Visit

    Augment develops cutting-edge artificial intelligence technologies to enhance the performance of knowledge workers across the enterprise.

  • BlueNote

    Blue Note Therapeutics

    Visit

    Blue Note Therapeutics leverages cutting-edge digital technology and neuroscience to commercialize prescription digital therapeutics for the treatment of serious medical conditions.

  • Embodied

    Embodied

    Visit

    Embodied, Inc. is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care and wellness by enhancing quality of life for individuals and families.

  • Eyefluence

    Eyefluence

    ACQUIRED BY GOOGLE. Eyefluence created the world’s first eye-interaction solution for augmented, virtual, and mixed reality devices. The Eyefluence iUi™ synchronizes neuroscience and technology to deliver the preeminent vision-driven user interface for head-mounted displays (HMDs).

  • Freeletics

    Freeletics

    Visit

    Freeletics combines psychological insights with digital technology and is the market leader in personalized coaching intelligence for optimizing physical fitness.

  • Halo

    Halo Neuroscience

    Visit

    Halo Neuroscience is developing powerful technology for improving motor and cognitive capabilities. Halo’s platform is used across the professional and consumer spectrum, from elite athletes and soldiers seeking ultimate performance to unlocking the full potential of individuals to learn new skills and knowledge.

  • Kami

    Kami Computing

    Visit

    Kami Computing leverages cognitive science and artificial intelligence in the commercialization of a “human operating system.” Kami’s technology is a fully autonomous and completely unscripted digital persona with an artificial but empathic and entertaining human consciousness.

  • LevelEx

    Level Ex

    Visit

    Level Ex creates industry-leading mobile, AR and VR games for physicians. The company uses state-of-the-art video game technology and cognitive neuroscience to capture the challenges of practicing medicine—revolutionizing the way physicians keep up-to-speed on rare and challenging cases, new medical devices and drug therapies to stay sharp in their specialties.

  • Limbix

    Limbix

    Visit

    Limbix develops technologies to enhance human performance across the spectrum from helping with disabilities to unlocking new capabilities. Limbix's virtual reality experiences treat a wide range of mental health conditions and optimize brain health.

  • Mahana

    Mahana Therapeutics

    Visit

    Mahana is developing breakthrough digital therapeutics that treat diseases, relieve suffering, and improve human performance.

  • NextStep

    NextStep

    Visit

    NextStep is developing an accelerated learning technology platform that enables workers in less-skilled jobs to unlock their full potential with new and exciting careers.

  • Pear

    Pear Therapeutics

    Visit

    Pear Therapeutics is pioneering the development of software solutions that improve human performance in those suffering from neurological disorders -- clinically-validated, FDA approved, prescription digital therapeutics that are ‘paired’ with specific pharmaceuticals to create new combination paradigms.

  • Perceptive Automata

    Perceptive Automata

    Visit

    Perceptive Automata is leveraging neuroscience to solve the hardest problem for robotic systems: understanding human behavior to enable symbiotic large-scale deployment of automated systems. Perceptive Automata provides human intuition for machines — impacting the future of autonomous vehicles and robots.

  • Pinpoint

    Pinpoint Predictive

    Visit

    Pinpoint Predictive leverages neuroscience and machine learning to create the first privacy-safe commercial applications of psychometric AI-powered targeting and insights.

  • Pymetrics

    Pymetrics

    Visit

    Pymetrics develops neuroscience-based human capital assessment software that enables companies to hire and retain the best employees.

  • RxRevu

    RxRevu

    Visit

    RxRevu helps physicians achieve peak performance and patients attain the best outcomes by providing critical information and clinical decision support technology at the point of care.

  • Thrive

    Thrive Global

    Visit

    Thrive Global develops software and digital media that leverage neuroscience to help corporate enterprises unlock and sustain peak performance through sustainable behavior change.

  • Two Bit Circus

    Two Bit Circus

    Visit

    Two Bit Circus is an experiential entertainment technology company that stimulates the sensorium, challenges the mind, and unlocks our potential to enjoy ourselves and each other in amazing new ways.

  • Wade & Wendy

    Wade & Wendy

    Visit

    Wade & Wendy is a software technology company that unlocks human potential by developing products that leverage advances in artificial intelligence to optimize the process of matching job-seekers with employers.

  • Wisdo

    Wisdo

    Visit

    Wisdo connects people with shared life experiences and aggregates the world’s wisdom.

  • Woebot

    Woebot

    Visit

    Woebot is the leader in artificial intelligence-driven care for mental health and wellbeing.

Continue reading

Partners

Our Team

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo fringilla vel aliquet nec vulputate eget arcu.

Andrew brings to JAZZ significant experience in venture capital, company building, technology development, and neurosurgery. He has served as founder, investor, director, and chairman of many successful companies. Prior to joining the firm, he was a general partner at Flare Capital. Previously, he was a venture partner at Sprout Group and a principal at Canaan Partners. Andrew has led numerous venture capital investments and has helped many early stage companies become market leaders. He was a founder (and invented the core technology) of Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). He also served as Chairman of IntElect Medical, which was acquired by Boston Scientific (NYSE: BSX). He currently serves as chairman of Functional Neuromodulation, a company developing brain stimulation therapy for Alzheimer’s disease. Representative prior investments and board roles include BridgePoint Medical (acquired by Boston Scientific, NYSE: BSX), Explorys (acquired by IBM, NYSE: IBM), Functional Neuromodulation, Halo Neuroscience, i1 Biometrics, Predilytics (acquired by Welltok), SetPoint Medical, Spine Wave, Vertos Medical, and Visiogen (acquired by Abbott, NYSE: ABT). During more than a decade in the healthcare profession as a neurosurgeon, he published more than 50 medical articles, wrote chapters for several medical textbooks, and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. As a board certified neurosurgeon, he served as clinical assistant professor of neurosurgery at the New York University School of Medicine. He currently serves on the Cornell Biomedical Engineering Advisory Council, the Advisory Council of the McGovern Center for Venture Development in Life Sciences at Cornell, and the Executive Board of the Yale Center for Biomedical and Interventional Technology. He has served on the Cornell University Council as chairman of the Technology Transfer Committee and member of the Life Sciences Advisory Board. He has also served as a member of the Innovation Advisory Board at the Cleveland Clinic. Andrew earned his M.D. from Weill Cornell University Medical College and his M.B.A. from the University of Pittsburgh after studying neuroscience at Cornell (A.B.) and Oxford University.

John is a seasoned investor, operating executive and corporate director and brings to JAZZ significant experience founding, funding and developing early-stage life sciences and technology companies. He has served as a founder, executive, corporate director, and investor to numerous companies, and has held executive in residence positions at Mayfield Fund and Versant Ventures and an Advisory Board position with Arboretum Ventures. Prior to JAZZ, John was the founder, President and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. NeuroVista was acquired by Cyberonics in 2013 (NASDAQ: CYBX). John was also a founder and the Vice President of Marketing and Business Development at Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). Prior to founding Northstar, he was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the market leader and can be found in airports, airplanes, stadiums, public buildings and many other locations. Heartstream went public in 1996, was subsequently acquired by Hewlett-Packard (NYSE: HPQ). John is also a cofounder of ClearFlow, MDI Partners, and VenX, and has held board positions with Setpoint Medical, Mirador Biomedical, ExoLabs and Norfil Manufacturing. John holds a BS in industrial engineering from Stanford University and an MBA from Northwestern University’s Kellogg School of Management.

Continue reading